Medical statistics

DNAnexus Platform Enables Researchers to Access and Analyze Biomedical Data for Largest Health Research Program in Mexico

Retrieved on: 
Tuesday, June 27, 2023
Technology, Biotechnology, Health, Other Health, Pharmaceutical, Professional Services, Other Science, Research, Software, General Health, Data Analytics, Genetics, Science, Data Management, Amazon Web Services, UK Biobank, Medical statistics, Privacy, National university, Data, DNAnexus, Principal, Death, AWS, Safety, UNAM, Medical device, Pharmaceutical industry, Epidemiology

DNAnexus Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced its platform is being used by researchers to access and analyze data from the Mexico City Prospective Study, the largest population health research study of its kind in Mexico.

Key Points: 
  • DNAnexus Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced its platform is being used by researchers to access and analyze data from the Mexico City Prospective Study, the largest population health research study of its kind in Mexico.
  • The Mexico City Prospective Study reflects a long-standing collaboration between Universidad Nacional Autónoma de México (UNAM) and Oxford Population Health.
  • “Our work with Oxford Population Health, DNAnexus, and AWS presents a unique opportunity for researchers in Mexico to advance medical research for the people of Mexico,” said Jesús Alegre-Díaz, Professor of Epidemiology at UNAM and Principal Investigator for the Mexico City Prospective Study.
  • “From this Mexico Prospective Study to the UK Biobank to Our Future Health, the DNAnexus platform continues to be the trusted platform of choice for the world’s largest biomedical research programs.

Scilex Holding Company Announces Complete Enrollment of a Phase 2 Study to Evaluate the Safety and Efficacy of SP-103 (lidocaine topical system) 5.4%, Triple Strength Formulation of ZTlido®, for the Treatment of Acute Low Back Pain

Retrieved on: 
Thursday, May 4, 2023
DSM-IV codes, Prevalence, Neck pain, PALO, Brand, United States drug overdose death rates and totals over time, LBP1, Prescription, Drug overdose, Grenfell Tower Inquiry Phase 2, Sensation, LBP, Death, Patient, Nonsteroidal anti-inflammatory drug, OTC, Pain management, Medical statistics, Pivotal, Trial of the century, FDA, Therapy, Chronic pain, Skin, Safety, Pharmaceutical industry, Dietary supplement, Lidocaine

The Phase 2, randomized, double-blind, placebo-controlled, parallel group, multicenter study will evaluate the safety and efficacy of SP-103 (lidocaine topical system) 5.4% in subjects with moderate to severe acute lower back pain (LBP).

Key Points: 
  • The Phase 2, randomized, double-blind, placebo-controlled, parallel group, multicenter study will evaluate the safety and efficacy of SP-103 (lidocaine topical system) 5.4% in subjects with moderate to severe acute lower back pain (LBP).
  • The trial is to enroll approximately 80 patients at 10 sites across the U.S. with acute LBP.
  • Scilex is developing SP-103 to be a triple-strength, non-aqueous lidocaine topical system for the treatment of acute LBP.
  • The outcome of the Phase 2 study should enable planning of a subsequent Pivotal Phase 3 trial.

New Music Video Becomes Anthem For National Opioid Crisis Awareness Campaign

Retrieved on: 
Thursday, April 27, 2023
Heart, Music, Travel, Singing, Lay Down Your Arms, Oscar, Ávila, Dirty Dancing, SC, Telephone, Parent, OH, Grundig, Hope, Anger, Human, The Ed Sullivan Show, Urban, History, Shyness, Death, Grief, Love, Child, Happiness, Pain management, Sound, Medical statistics, Drug, City, System, Rest, Fentanyl, Life, Eagle

NORWALK, Conn., April 27, 2023 /PRNewswire-PRWeb/ -- When Bruce James' longtime friend Robin Golden Trotter lost her daughter to fentanyl poisoning in 2019, the Hilton Head, SC, musician knew he had to do something. "My mission became very clear," says James, a singer/songwriter with five decades in the business. Released just this month, are the fruits of his labor, a new music video produced with Factory Underground Studio in Norwalk, CT, called "Dedicated to Life." [AVAILABLE HERE ON YOUTUBE] The song, written and composed by James in the pop/rock genre, delivers a message to young people to choose life, hope and love. It has been selected by APALD, a national organization dedicated to raising awareness for the opioid crisis facing so many people in the United States today, and will be played during a national rally day on May 6, 2023.

Key Points: 
  • It has been selected by APALD, a national organization dedicated to raising awareness for the opioid crisis facing so many people in the United States today, and will be played during a national rally day on May 6, 2023.
  • Like his new music video "Dedicated to Life," James frequently writes about timely social issues impacting the world around him.
  • The message of hope and the cause of raising awareness about the opioid crisis is also what spoke to Ethan Isaac (a Ridgefield, CT), co-owner of Factory Underground Studio , who is producing the music video.
  • "Our hope will be that the song and video will not only become an anthem song but also help bring awareness to the No.

Equality Health Foundation Expands Reach Across Multiple States

Retrieved on: 
Friday, April 21, 2023
St. Paul's Co-educational College, National Center for Health Statistics, Vaccine, National Center for Healthy Housing, Inc., Partnership, Aldine Independent School District, Health education, COVID-19, Life expectancy, Holiday, Community, Uvalde Consolidated Independent School District, Trustee, Centene Corporation, Superior, Medical statistics, Health, Family, AISD, Nursing, Aldine, Phoenix

HOUSTON, April 21, 2023 /PRNewswire-PRWeb/ -- Equality Health Foundation is expanding its reach of health and well-being services and support to a variety of diverse, underserved communities in Arizona, Texas, and Tennessee. The foundation aims to level the healthcare playing field for the state's culturally diverse and historically underserved neighborhoods. The nonprofit has had the opportunity to serve thousands of Arizona and Texas residents during this winter season by reducing health disparities, expanding access to care, and accelerating health education.

Key Points: 
  • HOUSTON, April 21, 2023 /PRNewswire-PRWeb/ -- Equality Health Foundation is expanding its reach of health and well-being services and support to a variety of diverse, underserved communities in Arizona, Texas, and Tennessee.
  • Equality Health Foundation recently helped break ground on a $7.9 million state-of-the-art multipurpose community center in Uvalde.
  • Equality Health Foundation leadership will participate in the executive committee overseeing the project, which is slated for completion in late 2024.
  • Equality Health Foundation will continue to support Texas residents with its third annual Houston Healthy Fall Festival.

AmeriHealth Caritas: Five Crucial Interventions to Improve Health Outcomes for Black Mothers

Retrieved on: 
Tuesday, April 11, 2023
Women, General Health, Health, Parenting, COVID-19, Family, Consumer, Other Health, National Center for Health Statistics, Medical statistics, Mortality, Death, Pregnancy, Woman, Multimedia, Black, Birth control, Medicaid

If you answered “The United States,” AmeriHealth Caritas says you would be correct.

Key Points: 
  • If you answered “The United States,” AmeriHealth Caritas says you would be correct.
  • In 2021, the U.S. maternal mortality rate hit its highest level since 1965, with deaths disproportionately impacting Black women:
    This press release features multimedia.
  • The maternal mortality rate for Black women was 69.9 deaths per 100,000 live births, compared to a rate of 26.6 per 100,000 for white women.
  • AmeriHealth Caritas, a national leader in Medicaid managed care and other health care solutions for those most in need, suggests five crucial interventions to improve outcomes for Black mothers as we recognize Black Maternal Health Week, April 11-17.

Groundbreaking Surgo Health Study Published in The Lancet is First to Link U.S. Maternal Health Outcomes to Community-Level Vulnerabilities

Retrieved on: 
Monday, April 3, 2023
National Center for Health Statistics, White House, Black–white binary, Pregnancy, MVI, PBC, Maternal health, Health equity, ZIP, Woman, SDOH, Research, Risk, Maternal death, Index, Mother, Patient, Preterm birth, Medical statistics, Mortality, Ageing, Substance abuse, Health, Bias, White, Environment, Mental health, Geography, Dietary supplement, Birth control, Black

"This is the first time anyone has quantified disparities in exposure to determinants of adverse health across the United States specifically for maternal health outcomes, nationwide, at a granular geographic level--and considered how multi-dimensional exposure contributes to the well-established racial disparities in maternal health outcomes," said Dr. Sema Sgaier, Chief Executive Officer of Surgo Health and a co-author of the study.

Key Points: 
  • The analysis confirmed marked geographic and racial/ethnic disparities in exposure to maternal vulnerability.
  • Surgo Health's groundbreaking study comes amid growing recognition of the country's maternal health crisis.
  • Previously, in June 2022, t he White House released a Maternal Health Blueprint for addressing the Maternal Health crisis, highlighting the need to address "social and economic forces" driving health inequity for pregnant women to improve maternal outcomes.
  • The Maternal Vulnerability Index (MVI) is a first-of-its-kind tool that can be used to examine racial disparities in drivers of maternal vulnerability to shed light on potential high-impact interventions to improve maternal health and maternal health equity.

PainReform Announces Commencement of Phase 3 Clinical Trial to Evaluate PRF-110 in Patients Undergoing Bunionectomy Surgery

Retrieved on: 
Tuesday, March 14, 2023
AUC, PK, Surgeon, Suture, Drug development, National Center for Health Research, Generally recognized as safe, TEL, Ropivacaine, Anesthetic, Trial of the century, Vital signs, Drug overdose, Probability, National Center for Health Statistics, Patient, Pain, Medical statistics, III, Physician, FDA, GRAS, Physical examination, Incidence, Wound healing, Safety, CDC, Hernia, Clinical trial, Centers for Disease Control and Prevention timeline, Morphine, NRS, Therapy, Pharmaceutical industry

The Phase 3 trial is a randomized, double-blind, placebo- and active-controlled, multicenter study to evaluate the analgesic efficacy and safety of intra-operative administration of PRF-110 following unilateral bunionectomy.

Key Points: 
  • The Phase 3 trial is a randomized, double-blind, placebo- and active-controlled, multicenter study to evaluate the analgesic efficacy and safety of intra-operative administration of PRF-110 following unilateral bunionectomy.
  • PRF-110 will be administered intra-operatively to measure peak blood concentration in order to further validate safety of the lead formulation.
  • Following the confirmation of peak blood levels, the study will proceed to the second, larger, part of the Phase 3 clinical trial.
  • Upon completion of the bunionectomy trial, we also plan to initiate the Phase 3 hernia repair clinical trial.

Aiberry Secures $8M in Seed Funding to Accelerate AI-Powered Mental Health Screenings

Retrieved on: 
Wednesday, March 8, 2023
Mental Health, Technology, Venture Capital, Health Technology, Telemedicine, Virtual Medicine, Professional Services, Software, General Health, Health, Artificial Intelligence, Linda, Newton, Depression, World Health Organization, Nervous, Diagnosis, Medical statistics, CCG, Brain, University of Oxford, Artificial intelligence, Research, School, Social, Suicidal ideation, Intelligence, Ascension, Patient, Mental health, Anxiety, Multimedia, Trust, National Center for Health Statistics, NCHS, Bias, VC, Mental, Organization, Georgetown University, National Center for Telehealth & Technology, Medical device, Nursing

Artificial intelligence (AI)-powered mental health screening pioneer Aiberry (pronounced “I” + “berry”) today announced that it has secured $8 million in seed funding led by Confluence Capital Group, Inc. (CCG) with participation from the VC fund Ascension AI.

Key Points: 
  • Artificial intelligence (AI)-powered mental health screening pioneer Aiberry (pronounced “I” + “berry”) today announced that it has secured $8 million in seed funding led by Confluence Capital Group, Inc. (CCG) with participation from the VC fund Ascension AI.
  • (Photo: Business Wire)
    Mental health issues are widespread and growing rapidly.
  • “AI platforms such as Aiberry provide a wide range of benefits compared to traditional diagnostic methods,” said Lynne Dunbrack, Group Vice President for IDC Health Insights.
  • This allows organizations to easily determine which mental health resource is the best investment for their specific needs and goals.

Motor Vehicle Deaths Again Reach an Estimated 46,000 in 2022

Retrieved on: 
Thursday, March 9, 2023
National Safety Council, Accident, Pedestrian, Medical statistics, Road, Council, Death, Crash, DOT, Language, National Center for Health Statistics, Fatality, Federation, Safe Streets Act, U.S. Department of Defense Strategy for Operating in Cyberspace, CDC, Safety, Transport, Infrastructure Investment and Jobs Act, Integrated safe system of work

WASHINGTON, March 9, 2023 /PRNewswire/ -- For a second consecutive year, preliminary estimates from the National Safety Council indicate the United States is in a dark place. Once again – in a single year's time – more than 46,000 people lost their lives in a preventable traffic crash; that's more than 46,000 people who didn't make it home to their families and loved ones in 2022. Estimates also reveal a staggering statistic: Compared to pre-pandemic 2019, the mileage death rate in 2022 increased nearly 22%, showing just how dangerous it is to use American roads.

Key Points: 
  • Estimates also reveal a staggering statistic: Compared to pre-pandemic 2019, the mileage death rate in 2022 increased nearly 22%, showing just how dangerous it is to use American roads.
  • "Words matter, and as a country, we need to learn and understand that there are no vehicle accidents.
  • Just a few months later, the National Roadway Safety Strategy was released by the U.S. Department of Transportation.
  • Motor vehicle fatality estimates are subject to slight increases and decreases as data mature.

American Cancer Society Releases New Colorectal Cancer Statistics; Rapid Shifts to More Advanced Disease and Younger People

Retrieved on: 
Wednesday, March 1, 2023
Tissue, Alaska Natives, Colonoscopy, SEER, American Cancer Society Cancer Action Network, Surveillance, Cancer, Human, Diagnosis, Disease, Policy, ACS, Mortality, National Center for Health Statistics, North American Association of Central Cancer Registries, Colorectal cancer, Lymph, Health equity, National Cancer Institute, Research, Medical statistics, CMS, BBB National Programs, Meat, American Cancer Society, National Center for Complementary and Integrative Health, Medicare, CRC, Cost sharing, Large intestine, Centers for Medicare & Medicaid Services, Woman, Incidence, Dairy, Health insurance, Vaccine, Pharmaceutical industry, Epidemiology

ATLANTA, March 1, 2023 /PRNewswire/ -- Colorectal cancer is swiftly shifting to more advanced disease and younger individuals according to Colorectal Cancer Statistics 2023, a new report on cancer facts and trends by the American Cancer Society (ACS).

Key Points: 
  • ATLANTA, March 1, 2023 /PRNewswire/ -- Colorectal cancer is swiftly shifting to more advanced disease and younger individuals according to Colorectal Cancer Statistics 2023, a new report on cancer facts and trends by the American Cancer Society (ACS).
  • Overall, in 2023, an estimated 153,020 people will be diagnosed with CRC in the U.S., and 52,550 people will die from the disease.
  • These major findings are to be published today in CA: A Cancer Journal for Clinicians , alongside its consumer-friendly companion, Colorectal Cancer Facts & Figures 2023-2025, available on cancer.org .
  • "These highly concerning data illustrate the urgent need to invest in targeted cancer research studies dedicated to understanding and preventing early-onset colorectal cancer," said Dr. Karen E. Knudsen , CEO of the American Cancer Society.